Determinants of timely administration of the birth dose of hepatitis B vaccine in Senegal in 2019: Secondary analysis of the demographic and health survey
Open Access
- 27 August 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (8) , e0002734
Abstract
In developing countries, hepatitis B is spread primarily by the perinatal or horizontal route. Thus, the Senegalese government recommends administering the birth dose of the hepatitis B vaccine (HepB0) within 24 hours of birth. The objective was to identify the determinants of timely administration of HepB0 in Senegal in 2019. A secondary analysis of the demographic and health survey was carried out. The study population consisted of children aged 12 to 23 months. A cluster survey, stratified in urban and rural areas, drawn at two stages, was carried out. Individual interviews were conducted. Logistic regression was applied to estimate the adjusted odds ratio (aOR) and their 95% confidence interval. In total, 1130 children were included. Among them, 48.1% were born to mothers aged 25 to 34, 46.8% were male and 82.6% were born in health facilities. The average time between birth and HepB0 administration was 13.1±46.6 days. The median is 0 days [IQR: 0–12] with a minimum of 0 days and a maximum of 414 days. Among 747 children vaccinated, only 65.2% were vaccinated within 24 hours of birth. The determinants were maternal age of at least 35 years (aOR = 2.03 [1.29–3.20]), primary education of the mother (aOR = 1.94 [1.13–3. 35]), at least four antenatal care visits (aOR = 1.74 [1.12–2.69]), belonging to the central (ORa = 0.22 [0.11–0.44]) and northern regions (aOR = 0.18 [0.08–0.40]), and delivery in a health facility (aOR = 3.42 [1.90–6.15]). Education and keeping girls in school, local postnatal care in hard-to-reach regions, promotion of antenatal acre and delivery in a health facility should improve the timeliness of HepB0 vaccination.Keywords
This publication has 18 references indexed in Scilit:
- Barriers and facilitators to hepatitis B birth dose vaccination: Perspectives from healthcare providers and pregnant women accessing antenatal care in NigeriaPLOS Global Public Health, 2023
- Hepatitis B prevention and treatment needs in women in Senegal (ANRS 12356 AmBASS survey)BMC Public Health, 2023
- Hepatitis BThe Lancet, 2023
- Beyond Vaccination Coverage: Population-Based Measurement of Early Childhood Immunization Schedule AdherenceAcademic Pediatrics, 2022
- Vaccination against tuberculosis, polio and hepatitis B at birth in Podor health district, Northern Senegal: cross-sectional study of vaccination coverage and its associated factorsBMC Public Health, 2022
- The coverage of hepatitis B birth dose vaccination in Nigeria: Does the place of delivery matter?Transactions of the Royal Society of Tropical Medicine and Hygiene, 2021
- The prevalence of HBsAg, knowledge and practice of hepatitis B prevention among pregnant women in the Limbe and Muyuka Health Districts of the South West region of Cameroon: a three-year retrospective studyPan African Medical Journal, 2019
- Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling studyThe Lancet Gastroenterology & Hepatology, 2018
- Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugsJournal of Hepatology, 2015
- Timeliness of Childhood Vaccinations in Kampala Uganda: A Community-Based Cross-Sectional StudyPLOS ONE, 2012